 | • レポートコード：MRC2-11QY10671 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胸腺癌治療のグローバル市場について調査・分析したレポートです。種類別（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胸腺癌治療の競争状況、市場シェア ・世界の胸腺癌治療市場：種類別市場規模 2015年-2020年（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他） ・世界の胸腺癌治療市場：種類別市場規模予測 2021年-2026年（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他） ・世界の胸腺癌治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の胸腺癌治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の胸腺癌治療市場分析：米国、カナダ ・ヨーロッパの胸腺癌治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胸腺癌治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胸腺癌治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胸腺癌治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck & Co., Inc.、Novartis AG、Onxeo SA、Sumitomo Dainippon Pharma Co., Ltd.、Taiwan Liposome Company, Ltd.、Tiziana Life Sciences Plc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Thymic Carcinoma Treatment Market
The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Thymic Carcinoma Treatment Scope and Market Size
Thymic Carcinoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thymic Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Thymic Carcinoma Treatment market is segmented into
Belinostat
Pasireotide ER
Milciclib
TLC-388
Others
Segment by Application, the Thymic Carcinoma Treatment market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Thymic Carcinoma Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Thymic Carcinoma Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Thymic Carcinoma Treatment Market Share Analysis
Thymic Carcinoma Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Thymic Carcinoma Treatment business, the date to enter into the Thymic Carcinoma Treatment market, Thymic Carcinoma Treatment product introduction, recent developments, etc.
The major vendors covered:
Merck & Co., Inc.
Novartis AG
Onxeo SA
Sumitomo Dainippon Pharma Co., Ltd.
Taiwan Liposome Company, Ltd.
Tiziana Life Sciences Plc
…
1 Study Coverage
1.1 Thymic Carcinoma Treatment Product Introduction
1.2 Market Segments
1.3 Key Thymic Carcinoma Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Thymic Carcinoma Treatment Market Size Growth Rate by Type
1.4.2 Belinostat
1.4.3 Pasireotide ER
1.4.4 Milciclib
1.4.5 TLC-388
1.4.6 Others
1.5 Market by Application
1.5.1 Global Thymic Carcinoma Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Thymic Carcinoma Treatment Market Size, Estimates and Forecasts
2.1.1 Global Thymic Carcinoma Treatment Revenue 2015-2026
2.1.2 Global Thymic Carcinoma Treatment Sales 2015-2026
2.2 Global Thymic Carcinoma Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Thymic Carcinoma Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Thymic Carcinoma Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Thymic Carcinoma Treatment Competitor Landscape by Players
3.1 Thymic Carcinoma Treatment Sales by Manufacturers
3.1.1 Thymic Carcinoma Treatment Sales by Manufacturers (2015-2020)
3.1.2 Thymic Carcinoma Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Thymic Carcinoma Treatment Revenue by Manufacturers
3.2.1 Thymic Carcinoma Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Thymic Carcinoma Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Thymic Carcinoma Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Thymic Carcinoma Treatment Revenue in 2019
3.2.5 Global Thymic Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Thymic Carcinoma Treatment Price by Manufacturers
3.4 Thymic Carcinoma Treatment Manufacturing Base Distribution, Product Types
3.4.1 Thymic Carcinoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Thymic Carcinoma Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Thymic Carcinoma Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Thymic Carcinoma Treatment Market Size by Type (2015-2020)
4.1.1 Global Thymic Carcinoma Treatment Sales by Type (2015-2020)
4.1.2 Global Thymic Carcinoma Treatment Revenue by Type (2015-2020)
4.1.3 Thymic Carcinoma Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Thymic Carcinoma Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Thymic Carcinoma Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Thymic Carcinoma Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Thymic Carcinoma Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Thymic Carcinoma Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Thymic Carcinoma Treatment Market Size by Application (2015-2020)
5.1.1 Global Thymic Carcinoma Treatment Sales by Application (2015-2020)
5.1.2 Global Thymic Carcinoma Treatment Revenue by Application (2015-2020)
5.1.3 Thymic Carcinoma Treatment Price by Application (2015-2020)
5.2 Thymic Carcinoma Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Thymic Carcinoma Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Thymic Carcinoma Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Thymic Carcinoma Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Thymic Carcinoma Treatment by Country
6.1.1 North America Thymic Carcinoma Treatment Sales by Country
6.1.2 North America Thymic Carcinoma Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Thymic Carcinoma Treatment Market Facts & Figures by Type
6.3 North America Thymic Carcinoma Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Thymic Carcinoma Treatment by Country
7.1.1 Europe Thymic Carcinoma Treatment Sales by Country
7.1.2 Europe Thymic Carcinoma Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Thymic Carcinoma Treatment Market Facts & Figures by Type
7.3 Europe Thymic Carcinoma Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Thymic Carcinoma Treatment by Region
8.1.1 Asia Pacific Thymic Carcinoma Treatment Sales by Region
8.1.2 Asia Pacific Thymic Carcinoma Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Thymic Carcinoma Treatment Market Facts & Figures by Type
8.3 Asia Pacific Thymic Carcinoma Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Thymic Carcinoma Treatment by Country
9.1.1 Latin America Thymic Carcinoma Treatment Sales by Country
9.1.2 Latin America Thymic Carcinoma Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Thymic Carcinoma Treatment Market Facts & Figures by Type
9.3 Central & South America Thymic Carcinoma Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Thymic Carcinoma Treatment by Country
10.1.1 Middle East and Africa Thymic Carcinoma Treatment Sales by Country
10.1.2 Middle East and Africa Thymic Carcinoma Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Thymic Carcinoma Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Thymic Carcinoma Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Corporation Information
11.1.2 Merck & Co., Inc. Description and Business Overview
11.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co., Inc. Thymic Carcinoma Treatment Products Offered
11.1.5 Merck & Co., Inc. Related Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description and Business Overview
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG Thymic Carcinoma Treatment Products Offered
11.2.5 Novartis AG Related Developments
11.3 Onxeo SA
11.3.1 Onxeo SA Corporation Information
11.3.2 Onxeo SA Description and Business Overview
11.3.3 Onxeo SA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Onxeo SA Thymic Carcinoma Treatment Products Offered
11.3.5 Onxeo SA Related Developments
11.4 Sumitomo Dainippon Pharma Co., Ltd.
11.4.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
11.4.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
11.4.3 Sumitomo Dainippon Pharma Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sumitomo Dainippon Pharma Co., Ltd. Thymic Carcinoma Treatment Products Offered
11.4.5 Sumitomo Dainippon Pharma Co., Ltd. Related Developments
11.5 Taiwan Liposome Company, Ltd.
11.5.1 Taiwan Liposome Company, Ltd. Corporation Information
11.5.2 Taiwan Liposome Company, Ltd. Description and Business Overview
11.5.3 Taiwan Liposome Company, Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Taiwan Liposome Company, Ltd. Thymic Carcinoma Treatment Products Offered
11.5.5 Taiwan Liposome Company, Ltd. Related Developments
11.6 Tiziana Life Sciences Plc
11.6.1 Tiziana Life Sciences Plc Corporation Information
11.6.2 Tiziana Life Sciences Plc Description and Business Overview
11.6.3 Tiziana Life Sciences Plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Tiziana Life Sciences Plc Thymic Carcinoma Treatment Products Offered
11.6.5 Tiziana Life Sciences Plc Related Developments
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Corporation Information
11.1.2 Merck & Co., Inc. Description and Business Overview
11.1.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co., Inc. Thymic Carcinoma Treatment Products Offered
11.1.5 Merck & Co., Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Thymic Carcinoma Treatment Market Estimates and Projections by Region
12.1.1 Global Thymic Carcinoma Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Thymic Carcinoma Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Thymic Carcinoma Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Thymic Carcinoma Treatment Sales Forecast (2021-2026)
12.2.2 North America: Thymic Carcinoma Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Thymic Carcinoma Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Thymic Carcinoma Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Thymic Carcinoma Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Thymic Carcinoma Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Thymic Carcinoma Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Thymic Carcinoma Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Thymic Carcinoma Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Thymic Carcinoma Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Thymic Carcinoma Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Thymic Carcinoma Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Thymic Carcinoma Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Thymic Carcinoma Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Thymic Carcinoma Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Thymic Carcinoma Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Thymic Carcinoma Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Thymic Carcinoma Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Thymic Carcinoma Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Thymic Carcinoma Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Thymic Carcinoma Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Thymic Carcinoma Treatment Market Segments
Table 2. Ranking of Global Top Thymic Carcinoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Thymic Carcinoma Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Belinostat
Table 5. Major Manufacturers of Pasireotide ER
Table 6. Major Manufacturers of Milciclib
Table 7. Major Manufacturers of TLC-388
Table 8. Major Manufacturers of Others
Table 9. Global Thymic Carcinoma Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Thymic Carcinoma Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Thymic Carcinoma Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Thymic Carcinoma Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global Thymic Carcinoma Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Thymic Carcinoma Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Thymic Carcinoma Treatment Sales Share by Manufacturers (2015-2020)
Table 16. Global Thymic Carcinoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Thymic Carcinoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thymic Carcinoma Treatment as of 2019)
Table 18. Thymic Carcinoma Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Thymic Carcinoma Treatment Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Thymic Carcinoma Treatment Price (2015-2020) (USD/Pcs)
Table 21. Thymic Carcinoma Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Thymic Carcinoma Treatment Product Type
Table 23. Date of International Manufacturers Enter into Thymic Carcinoma Treatment Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 26. Global Thymic Carcinoma Treatment Sales Share by Type (2015-2020)
Table 27. Global Thymic Carcinoma Treatment Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Thymic Carcinoma Treatment Revenue Share by Type (2015-2020)
Table 29. Thymic Carcinoma Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 31. Global Thymic Carcinoma Treatment Sales Share by Application (2015-2020)
Table 32. North America Thymic Carcinoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 33. North America Thymic Carcinoma Treatment Sales Market Share by Country (2015-2020)
Table 34. North America Thymic Carcinoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Thymic Carcinoma Treatment Revenue Market Share by Country (2015-2020)
Table 36. North America Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 37. North America Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Table 38. North America Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 39. North America Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Table 40. Europe Thymic Carcinoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Thymic Carcinoma Treatment Sales Market Share by Country (2015-2020)
Table 42. Europe Thymic Carcinoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Thymic Carcinoma Treatment Revenue Market Share by Country (2015-2020)
Table 44. Europe Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Table 46. Europe Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Thymic Carcinoma Treatment Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Thymic Carcinoma Treatment Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Thymic Carcinoma Treatment Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Thymic Carcinoma Treatment Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Table 56. Latin America Thymic Carcinoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Thymic Carcinoma Treatment Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Thymic Carcinoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Thymic Carcinoma Treatment Revenue Market Share by Country (2015-2020)
Table 60. Latin America Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Table 62. Latin America Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Thymic Carcinoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Thymic Carcinoma Treatment Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Thymic Carcinoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Thymic Carcinoma Treatment Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Thymic Carcinoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Thymic Carcinoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Table 72. Merck & Co., Inc. Corporation Information
Table 73. Merck & Co., Inc. Description and Major Businesses
Table 74. Merck & Co., Inc. Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Merck & Co., Inc. Product
Table 76. Merck & Co., Inc. Recent Development
Table 77. Novartis AG Corporation Information
Table 78. Novartis AG Description and Major Businesses
Table 79. Novartis AG Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Novartis AG Product
Table 81. Novartis AG Recent Development
Table 82. Onxeo SA Corporation Information
Table 83. Onxeo SA Description and Major Businesses
Table 84. Onxeo SA Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Onxeo SA Product
Table 86. Onxeo SA Recent Development
Table 87. Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
Table 88. Sumitomo Dainippon Pharma Co., Ltd. Description and Major Businesses
Table 89. Sumitomo Dainippon Pharma Co., Ltd. Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Sumitomo Dainippon Pharma Co., Ltd. Product
Table 91. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 92. Taiwan Liposome Company, Ltd. Corporation Information
Table 93. Taiwan Liposome Company, Ltd. Description and Major Businesses
Table 94. Taiwan Liposome Company, Ltd. Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Taiwan Liposome Company, Ltd. Product
Table 96. Taiwan Liposome Company, Ltd. Recent Development
Table 97. Tiziana Life Sciences Plc Corporation Information
Table 98. Tiziana Life Sciences Plc Description and Major Businesses
Table 99. Tiziana Life Sciences Plc Thymic Carcinoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Tiziana Life Sciences Plc Product
Table 101. Tiziana Life Sciences Plc Recent Development
Table 102. Global Thymic Carcinoma Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 103. Global Thymic Carcinoma Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 104. Global Thymic Carcinoma Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 105. Global Thymic Carcinoma Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 106. North America: Thymic Carcinoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. North America: Thymic Carcinoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Europe: Thymic Carcinoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Europe: Thymic Carcinoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Asia Pacific: Thymic Carcinoma Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 111. Asia Pacific: Thymic Carcinoma Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 112. Latin America: Thymic Carcinoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 113. Latin America: Thymic Carcinoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 114. Middle East and Africa: Thymic Carcinoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 115. Middle East and Africa: Thymic Carcinoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 117. Key Challenges
Table 118. Market Risks
Table 119. Main Points Interviewed from Key Thymic Carcinoma Treatment Players
Table 120. Thymic Carcinoma Treatment Customers List
Table 121. Thymic Carcinoma Treatment Distributors List
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Thymic Carcinoma Treatment Product Picture
Figure 2. Global Thymic Carcinoma Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Belinostat Product Picture
Figure 4. Pasireotide ER Product Picture
Figure 5. Milciclib Product Picture
Figure 6. TLC-388 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Thymic Carcinoma Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Thymic Carcinoma Treatment Report Years Considered
Figure 13. Global Thymic Carcinoma Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global Thymic Carcinoma Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global Thymic Carcinoma Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Thymic Carcinoma Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global Thymic Carcinoma Treatment Sales Market Share by Region in 2019
Figure 18. Global Thymic Carcinoma Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global Thymic Carcinoma Treatment Revenue Market Share by Region in 2019
Figure 20. Global Thymic Carcinoma Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Thymic Carcinoma Treatment Revenue in 2019
Figure 22. Thymic Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Thymic Carcinoma Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global Thymic Carcinoma Treatment Sales Market Share by Type in 2019
Figure 25. Global Thymic Carcinoma Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global Thymic Carcinoma Treatment Revenue Market Share by Type in 2019
Figure 27. Global Thymic Carcinoma Treatment Market Share by Price Range (2015-2020)
Figure 28. Global Thymic Carcinoma Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global Thymic Carcinoma Treatment Sales Market Share by Application in 2019
Figure 30. Global Thymic Carcinoma Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global Thymic Carcinoma Treatment Revenue Market Share by Application in 2019
Figure 32. North America Thymic Carcinoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Thymic Carcinoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Thymic Carcinoma Treatment Sales Market Share by Country in 2019
Figure 35. North America Thymic Carcinoma Treatment Revenue Market Share by Country in 2019
Figure 36. U.S. Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Thymic Carcinoma Treatment Market Share by Type in 2019
Figure 41. North America Thymic Carcinoma Treatment Market Share by Application in 2019
Figure 42. Europe Thymic Carcinoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Thymic Carcinoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Thymic Carcinoma Treatment Sales Market Share by Country in 2019
Figure 45. Europe Thymic Carcinoma Treatment Revenue Market Share by Country in 2019
Figure 46. Germany Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Thymic Carcinoma Treatment Market Share by Type in 2019
Figure 57. Europe Thymic Carcinoma Treatment Market Share by Application in 2019
Figure 58. Asia Pacific Thymic Carcinoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Thymic Carcinoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Thymic Carcinoma Treatment Sales Market Share by Region in 2019
Figure 61. Asia Pacific Thymic Carcinoma Treatment Revenue Market Share by Region in 2019
Figure 62. China Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Thymic Carcinoma Treatment Market Share by Type in 2019
Figure 85. Asia Pacific Thymic Carcinoma Treatment Market Share by Application in 2019
Figure 86. Latin America Thymic Carcinoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Thymic Carcinoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Thymic Carcinoma Treatment Sales Market Share by Country in 2019
Figure 89. Latin America Thymic Carcinoma Treatment Revenue Market Share by Country in 2019
Figure 90. Mexico Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Thymic Carcinoma Treatment Market Share by Type in 2019
Figure 97. Latin America Thymic Carcinoma Treatment Market Share by Application in 2019
Figure 98. Middle East and Africa Thymic Carcinoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Thymic Carcinoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Thymic Carcinoma Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Thymic Carcinoma Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Thymic Carcinoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Thymic Carcinoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Thymic Carcinoma Treatment Market Share by Type in 2019
Figure 109. Middle East and Africa Thymic Carcinoma Treatment Market Share by Application in 2019
Figure 110. North America Thymic Carcinoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Thymic Carcinoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Thymic Carcinoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Thymic Carcinoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Thymic Carcinoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Thymic Carcinoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Thymic Carcinoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Thymic Carcinoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Thymic Carcinoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Thymic Carcinoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…- 尿路上皮がん治療の世界市場（～2026年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
- 結腸・直腸がんの世界市場（～2026年） Market Analysis and Insights: Global Colon & Rectal Carcinoma Market The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Colon & Rectal Carcinoma Scope and Market Size Colon & Rectal Car…
- 神経内分泌がんの世界市場（～2026年） Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …